Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol.

Meyerhoff DJ, Murray DE, Durazzo TC, Pennington DL.

Front Psychiatry. 2018 Mar 15;9:78. doi: 10.3389/fpsyt.2018.00078. eCollection 2018.

2.

An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines.

Zaman T, Rife TL, Batki SL, Pennington DL.

Subst Abus. 2018 Mar 29:1-8. doi: 10.1080/08897077.2018.1455163. [Epub ahead of print]

PMID:
29595408
3.

Mobile Technology for Treatment Augmentation in Veteran Smokers With Posttraumatic Stress Disorder.

Herbst E, Pennington D, Kuhn E, McCaslin SE, Delucchi K, Batki SL, Dickter B, Carmody T.

Am J Prev Med. 2018 Jan;54(1):124-128. doi: 10.1016/j.amepre.2017.08.016. Epub 2017 Oct 23.

PMID:
29074319
4.

Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.

Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL.

Addiction. 2018 Feb;113(2):268-278. doi: 10.1111/add.13950. Epub 2017 Aug 29.

PMID:
28734107
5.

Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.

Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC.

J Clin Psychiatry. 2016 Sep;77(9):1182-1188. doi: 10.4088/JCP.15m09893.

PMID:
27035058
6.

Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Schmidt TP, Pennington DL, Cardoos SL, Durazzo TC, Meyerhoff DJ.

J Clin Exp Neuropsychol. 2017 Feb;39(1):22-34. Epub 2016 Oct 3.

7.

Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.

Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):21-30. doi: 10.1097/QAI.0000000000000922.

8.

What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?

Batki SL.

J Clin Psychiatry. 2015 Oct;76(10):e1336-7. doi: 10.4088/JCP.14com09611. No abstract available.

9.

Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.

Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH.

J Psychiatr Res. 2015 Oct;69:150-7. doi: 10.1016/j.jpsychires.2015.07.016. Epub 2015 Jul 22.

PMID:
26343607
10.

Alcohol use disorder with and without stimulant use: brain morphometry and its associations with cigarette smoking, cognition, and inhibitory control.

Pennington DL, Durazzo TC, Schmidt TP, Abé C, Mon A, Meyerhoff DJ.

PLoS One. 2015 Mar 24;10(3):e0122505. doi: 10.1371/journal.pone.0122505. eCollection 2015.

11.

A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder.

Pennington DL, Abé C, Batki SL, Meyerhoff DJ.

Psychiatry Res. 2014 Dec 30;224(3):281-7. doi: 10.1016/j.pscychresns.2014.09.004. Epub 2014 Sep 16.

12.

Behavioral treatment of insomnia in early recovery.

Kaplan KA, McQuaid J, Batki SL, Rosenlicht N.

J Addict Med. 2014 Nov-Dec;8(6):395-8. doi: 10.1097/ADM.0000000000000058. No abstract available.

PMID:
25369939
13.

Effects of cigarette smoking history on neurocognitive recovery over 8 months of abstinence in alcohol-dependent individuals.

Durazzo TC, Pennington DL, Schmidt TP, Meyerhoff DJ.

Alcohol Clin Exp Res. 2014 Nov;38(11):2816-25. doi: 10.1111/acer.12552. Epub 2014 Oct 21.

14.

Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol.

Hoefer ME, Pennington DL, Durazzo TC, Mon A, Abé C, Truran D, Hutchison KE, Meyerhoff DJ.

Alcohol. 2014 Nov;48(7):631-8. doi: 10.1016/j.alcohol.2014.08.007. Epub 2014 Aug 27.

15.

Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.

Batki SL, Pennington DL, Lasher B, Neylan TC, Metzler T, Waldrop A, Delucchi K, Herbst E.

Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. Epub 2014 Aug 4.

16.

Cognitive-behavioral therapy in depressed primary care patients with co-occurring problematic alcohol use: effect of telephone-administered vs. face-to-face treatment-a secondary analysis.

Kalapatapu RK, Ho J, Cai X, Vinogradov S, Batki SL, Mohr DC.

J Psychoactive Drugs. 2014 Apr-Jun;46(2):85-92. doi: 10.1080/02791072.2013.876521.

17.

Postural stability in cigarette smokers and during abstinence from alcohol.

Schmidt TP, Pennington DL, Durazzo TC, Meyerhoff DJ.

Alcohol Clin Exp Res. 2014 Jun;38(6):1753-60. doi: 10.1111/acer.12409. Epub 2014 Apr 9.

18.

Team-based learning exercise efficiently teaches brief intervention skills to medicine residents.

Wamsley MA, Julian KA, O'Sullivan P, McCance-Katz EF, Batki SL, Satre DD, Satterfield J.

Subst Abus. 2013;34(4):344-9. doi: 10.1080/08897077.2013.787958.

PMID:
24159904
19.

Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder.

Kalapatapu RK, Delucchi KL, Lasher BA, Vinogradov S, Batki SL.

Mil Med. 2013 Sep;178(9):974-80. doi: 10.7205/MILMED-D-13-00097.

20.

Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders.

Kalapatapu RK, Lewis DF, Vinogradov S, Batki SL, Winhusen T.

J Addict Dis. 2013;32(2):206-16. doi: 10.1080/10550887.2013.795471.

Supplemental Content

Loading ...
Support Center